Tag: discontinuation

Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.

Peter Gøtzsche gives advice on what withdrawal symptoms may look like and explains the dangers of—and alternatives to—forced treatment.

Psychiatrists have made hundreds of millions of people dependent on psychiatric drugs and yet have done virtually nothing to find out how to help the patients come off them again.

Peter Gøtzsche: The MIND organization in Denmark and the psychiatric guild suppressed information regarding the discontinuation of psychiatric drugs.

Very few doctors know anything about withdrawal and make horrible mistakes. If they taper at all, they do it far too quickly because the few guidelines that exist recommend far too quick tapering.

Anti-stigma campaigns reinforce a belief that people with mental health issues must have treatment and thus, push discussion of withdrawal and negative aspects of psychiatric drugs into anonymous spaces.

Researchers find a lack of current literature on safe, effective ways to manage antidepressant withdrawal and make suggestions for future research.

A new article discusses the lack of research dedicated to discontinuing psychiatric drugs and reviews existing strategies.

Online withdrawal forums document an assortment of risks associated with discontinuation of psychiatric drugs. Such information is readily available and must be disclosed during informed consent.

Online communities are stepping in to help people facing withdrawal effects amass information and receive support for their withdrawal experiences.

Sami Timimi provides a discussion of the ways medication may be helpful for some, and advice and information on discontinuing psychiatric drugs.

A new study looks at how online communities provide information and support for patients experiencing psychiatric drug withdrawal.

Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.

MIA's Madison Natarajan interviews Natalie Campo about integrative psychiatry and holistic approaches to drug tapering and withdrawal.

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.

After suffering PTSD in the late 1980s, I reluctantly accepted antidepressants. In time, I had resolved the trauma, but when I tried to stop the antidepressants (Prozac, and later Zoloft), I assumed my desperate feelings and “return” of depression were an indication I had an imbalance and needed those drugs. I didn’t understand I was experiencing withdrawal. (I was never told that for most people, psychiatric medications need to be tapered.)

A recently published study from noted critical psychiatry expert Joanna Moncrieff explored the barriers that prevent clinicians from helping service users in discontinuing or...

Recent claims about antidepressant effectiveness have been based on misleading statements and misunderstandings of the science.

Study reviews psychological interventions for antidepressant discontinuation.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

Meta-analysis of antidepressant tapering finds CBT and MBCT can aid in tapering, but limited studies met inclusion criteria.

In the interest of the patients who are currently experiencing withdrawal reactions and the many more who will suffer withdrawal effects in the future, we need to end this “war.” Academic psychiatry must address these problems and conduct thorough research on withdrawal reactions.